Nubeqa, ADT Combo Should Be New Standard of Care for Some Patients with Prostate Cancer by admin_63069 | Mar 6, 2023 | Related Topics The combination demonstrated survival benefit in patients with metastatic hormone-sensitive prostate cancer, regardless of risk or volume of disease.